5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.36▼ | 5.33▼ | 5.23▲ | 4.86▲ | 7.69▼ |
MA10 | 5.28▼ | 5.15▲ | 5.06▲ | 6.02▼ | 10.95▼ |
MA20 | 5.08▲ | 4.97▲ | 4.91▲ | 7.74▼ | 8.79▼ |
MA50 | 4.88▲ | 4.67▲ | 5.75▼ | 11.34▼ | 7.43▼ |
MA100 | 4.95▲ | 7.02▼ | 7.96▼ | 8.92▼ | 7.83▼ |
MA200 | 7.55▼ | 11.63▼ | 11.98▼ | 7.69▼ | 15.91▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.015▲ | 0.085▲ | 0.152▲ | -0.244▼ | -0.688▼ |
RSI | 58.299▲ | 56.818▲ | 52.304▲ | 31.357▼ | 44.067▼ |
STOCH | 66.544 | 77.991 | 78.912 | 11.652▼ | 9.629▼ |
WILL %R | -50.000 | -34.000 | -34.000 | -79.057▼ | -95.451▼ |
CCI | 32.737 | 74.328 | 106.829▲ | -48.789 | -93.323 |
Wednesday, September 10, 2025 05:59 AM
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...
|
Tuesday, September 09, 2025 06:27 AM
The aggregate gross proceeds from the offering were approximately $3.0 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the ...
|
Thursday, September 04, 2025 03:16 PM
The shares of common stock and pre-funded warrants are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-273153), which was filed with the U.S.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/09/25 | 4.85 | 5.75 | 4.85 | 5.31 | 191,180 |
11/09/25 | 4.71 | 5.10 | 4.60 | 4.92 | 111,868 |
10/09/25 | 4.66 | 5.10 | 4.65 | 4.83 | 134,071 |
09/09/25 | 4.60 | 4.79 | 4.60 | 4.68 | 124,102 |
08/09/25 | 4.50 | 4.60 | 4.4068 | 4.55 | 196,446 |
05/09/25 | 4.48 | 4.70 | 4.30 | 4.51 | 235,502 |
04/09/25 | 4.40 | 4.66 | 4.20 | 4.35 | 618,010 |
03/09/25 | 8.48 | 9.00 | 7.52 | 8.76 | 414,785 |
02/09/25 | 8.52 | 9.25 | 8.52 | 9.05 | 10,868 |
29/08/25 | 9.15 | 9.38 | 9.02 | 9.25 | 13,621 |
|
|
||||
|
|
||||
|
|